What is CVE-2022-26240?

CVE-2022-26240 is a medium-severity vulnerability in Beckmancoulter Remisol Advance, classified under Incorrect Permission Assignment for Critical Resource. CVSS score: 6.5/10. Published 2022-10-06.

How severe is CVE-2022-26240?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Vulnerability in Beckmancoulter Remisol Advance

CVE-2022-26240

The default privileges for the running service Normand Message Buffer in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

Published 2022-10-06 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.006 (48.3th percentile), scored 2026-10-01.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 48th percentile — 48.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: +0.000

Affected products

Weakness classification (CWE)

CWE-732 — Incorrect Permission Assignment for Critical Resource

References

www.beckmancoulter.com/products/clinical-information-management-tools/remisol-a… (Product)
pastebin.com/Bsy6KTxJ (Third Party Advisory)

Frequently asked questions

What is CVE-2022-26240?: CVE-2022-26240 is a medium-severity vulnerability in Beckmancoulter Remisol Advance, classified under Incorrect Permission Assignment for Critical Resource. CVSS score: 6.5/10. Published 2022-10-06.
How severe is CVE-2022-26240?: Medium severity. CVSS v3 base score is 6.5 out of 10.